Gerard van Hamel Platerink
Chairman of the Board
Gerard van Hamel Platerink has served on the Augmedix board of directors since June 2012 and has served as Chairman of the board of directors since August 2020. Mr. van Hamel Platerink currently serves as a Managing Director of Redmile Group, LLC, a healthcare focused investment firm, which he joined in May 2012. Prior to joining Redmile, Mr. van Hamel Platerink was a Managing Director with Accuitive Medical Ventures, a healthcare venture capital firm from 2003 to 2012. Mr. van Hamel Platerink holds a B.S. in Physics from the University of St. Andrews, and an M.B.A. from University of Cambridge.
Chief Executive Officer and Board Member
Emmanuel “Manny” Krakaris is the President, Chief Executive Officer, and Secretary of Augmedix. Mr. Krakaris has been a member of the Augmedix board of directors since October 2018. Prior to Augmedix, Mr. Krakaris served as the Chief Executive Officer of Streetline, Inc. from August 2014 to February 2018 and as Chief Financial Officer and Chief Operating Officer from 2011 to August 2014. Mr. Krakaris also served as Chief Financial Officer of Command Audio Corporation from 1996 to 2011. Mr. Krakaris received a Bachelor of Commerce in Marketing and International Business from McGill University, and a M.B.A. from the University of California, Berkeley, Haas School of Business.
Founder, Chief Strategy Officer, and Board Member
Ian Shakil is the founder of Augmedix and has served as Chief Strategy Officer since October 2018. Mr. Shakil has been a member of the Augmedix board since April 2013. From April 2013 to October 2018, Mr. Shakil served as the Chief Executive Officer of Augmedix. Mr. Shakil has also served as Advisor to Edwards Lifesciences Corporation since May 2019, and as Advisor to Maya.com.bd since January 2018. Mr. Shakil has a B.S.E. in Biomedical Engineering from Duke University, and an M.B.A. from Stanford University Graduate School of Business.
Jennifer Carter has served as a Director of Augmedix since June 2020. Since April 2015, Ms. Carter has served in various roles at McKesson Ventures, including as Vice President of Portfolio Development and Marketing from April 2015 to September 2019, and as Vice President of Venture Operations from September 2019 to June 2020, then Vice President of Portfolio Development from June 2020 to present. Ms. Carter holds a B.A. in Economics from Boston College Caroll School of Management.
Jason Krikorian has served as a Director of Augmedix since May 2017. Mr. Krikorian currently serves as a General Partner at DCM, a venture capital firm, which he joined in July 2010. Prior to joining DCM, Mr. Krikorian co-founded Sling Media, Inc., a digital media and device company. Mr. Krikorian holds a B.A. in Psychology from the University of California, Berkeley, a J.D. from the University of Virginia School of Law, and a M.B.A. from the University of Virginia Darden School of Business.
Joseph Marks, Ph.D. has served as a Director of Augmedix since January 2020. He is currently Chief Technology Officer for Weta Digital Ltd., a digital visual effects company, which he joined in September 2020. Dr. Marks is also Executive Director of the Center for Machine Learning and Health at Carnegie Mellon University, where he has served since May 2016. Dr. Marks co-founded Caboodle Technologies, Inc. in April 2018. Prior to that, Dr. Marks was Co-Founder of Upfront Analytics, LTD, based in Dublin, Ireland. Dr. Marks holds an A.B. in Applied Mathematics, as well as a Master of Science and Ph.D. in Computer Science, all from Harvard University.